Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	101.66	81.57	40.45
Graham Fair Price	257.01	40.92	11.46
PEG	-99.45	< 0.005	-1.27
Price/Book	-40.16	2.90	4.85
Price/Cash Flow	-56.85	-15.13	35.06
Prices/Earnings	-82.31	-5.25	29.65
Price/Sales	37.89	7.41	5.37
Price/FCF	-56.85	-15.13	35.06
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-5.15	0.15	0.16
Operating Margin	-63.61	0.05	0.14
ROA	536.23	-0.05	< 0.005
ROE	0.04	-0.14	238.24
ROIC	0.03	< 0.005	-72.52
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.32	-0.10	-208.85
Dividends QOQ	< 0.005	< 0.005	10.34
EBIT QOQ	0.20	-0.69	252.14
EPS QOQ	-0.23	-7.55	-3121.77
FCF QOQ	-0.04	-3.69	-8625.43
Revenue QOQ	-0.04	-0.16	-295.43
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	49.06	55.48	13.09
Days Sales Outstanding (DSO)	61.78	95.95	55.30
Inventory Turnover	1.83	1.62	-11.58
Debt/Capitalization	0.70	0.45	-36.04
Quick Ratio	0.49	0.89	80.01
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	11.95	23.20	94.12
Cash	2.29	5.52	141.19
Capex	-0.68	-0.49	28.29
Free Cash Flow	1.65	-4.45	169.21
Revenue	10.78	9.08	-15.76
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.79	1.21	53.48
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	12.65	14.07	11.29
Naive Interpretation	Member

06 - Financial Health · Weak

Rating